Real-world data on the effect of long-term treatment with nusinersen over > 4 years in a cohort of Swiss patients with spinal muscular atrophy

Key Points

• Patients showed sustained improvement in motor function after long-term treatment with nusinersen, indicating therapeutic value.
• The study analyzed real-world data from Swiss patients over more than four years, covering treatment outcomes and health metrics.
• Assessment involved tracking changes in motor skills and function, focusing on the impact of sustained nusinersen therapy.
• The findings highlight the importance of long-term treatment strategies in managing spinal muscular atrophy and improving quality of life.